HRP20100254T1 - Transdermalni sustav za davanje gestodena - Google Patents

Transdermalni sustav za davanje gestodena Download PDF

Info

Publication number
HRP20100254T1
HRP20100254T1 HR20100254T HRP20100254T HRP20100254T1 HR P20100254 T1 HRP20100254 T1 HR P20100254T1 HR 20100254 T HR20100254 T HR 20100254T HR P20100254 T HRP20100254 T HR P20100254T HR P20100254 T1 HRP20100254 T1 HR P20100254T1
Authority
HR
Croatia
Prior art keywords
drug
layer
gestoden
preparation according
weight
Prior art date
Application number
HR20100254T
Other languages
English (en)
Croatian (hr)
Inventor
Langguth Thomas
Bracht Stefan
Dittgen Michael
Huber Petra
Schenk Drik
Original Assignee
Bayer Schering Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34924031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20100254(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Aktiengesellschaft filed Critical Bayer Schering Pharma Aktiengesellschaft
Publication of HRP20100254T1 publication Critical patent/HRP20100254T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20100254T 2003-12-12 2010-05-04 Transdermalni sustav za davanje gestodena HRP20100254T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03078881 2003-12-12

Publications (1)

Publication Number Publication Date
HRP20100254T1 true HRP20100254T1 (hr) 2010-06-30

Family

ID=34924031

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20100254T HRP20100254T1 (hr) 2003-12-12 2010-05-04 Transdermalni sustav za davanje gestodena
HRP20140077TT HRP20140077T1 (hr) 2003-12-12 2014-01-24 Transdermalni sustav za davanje hormona bez sredstava za pospješivanje prodiranja

Family Applications After (1)

Application Number Title Priority Date Filing Date
HRP20140077TT HRP20140077T1 (hr) 2003-12-12 2014-01-24 Transdermalni sustav za davanje hormona bez sredstava za pospješivanje prodiranja

Country Status (23)

Country Link
EP (2) EP1541137B1 (fr)
CN (1) CN101843603B (fr)
AR (1) AR046762A1 (fr)
AT (1) ATE457168T1 (fr)
CR (1) CR8465A (fr)
CY (2) CY1110637T1 (fr)
DE (1) DE602004025444D1 (fr)
DK (2) DK1541137T3 (fr)
ES (2) ES2445690T3 (fr)
GT (1) GT200400262A (fr)
HN (1) HN2004000526A (fr)
HR (2) HRP20100254T1 (fr)
JO (1) JO2606B1 (fr)
ME (1) ME01069B (fr)
MY (2) MY144053A (fr)
PE (1) PE20051035A1 (fr)
PL (2) PL1541137T3 (fr)
PT (2) PT2138169E (fr)
RS (2) RS51260B (fr)
SI (2) SI2138169T1 (fr)
SV (1) SV2006001970A (fr)
TW (1) TWI257299B (fr)
UA (1) UA89766C2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073696A1 (fr) 2003-02-21 2004-09-02 Schering Ag Pansement transdermique stable aux uv
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
WO2010042610A1 (fr) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Administration transdermique
WO2010042607A1 (fr) 2008-10-08 2010-04-15 Agile Therapeutics, Inc Administration transdermique
WO2010042612A1 (fr) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Délivrance transdermique
EP2410859A4 (fr) * 2009-03-27 2013-03-13 Agile Therapeutics Inc Administration transdermique
SI2613772T1 (sl) 2010-09-06 2017-03-31 Bayer Intellectual Property Gmbh Transdermalni obliži z nizkim odmerkom z visoko stopnjo sproščanja zdravila
AU2015203180B2 (en) * 2010-09-06 2016-06-30 Bayer Intellectual Property Gmbh Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
DE102010040299A1 (de) * 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
HK1204287A1 (en) * 2012-01-27 2015-11-13 敏捷治疗公司 Transdermal hormone delivery

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081537A (en) 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof
HU210549B (en) * 1988-10-27 1995-05-29 Schering Ag Process for producing transdermally applicable pharmaceutical composition containing gestodene
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
MX9101787A (es) 1990-10-29 1992-06-05 Alza Corp Formulaciones,metodos y dispositivos anticonceptivos transdermicos
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4329242A1 (de) 1993-08-26 1995-03-02 Schering Ag Mittel zur transdermalen Applikation enthaltend Gestodenester
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
US5762956A (en) 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
KR100758757B1 (ko) 1999-11-24 2007-09-14 애자일 쎄라퓨틱스, 인크. 개량된 경피적 피임제 송달시스템 및 송달방법
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
US20020106402A1 (en) 2000-12-05 2002-08-08 Hartwig Rod Lawson Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use

Also Published As

Publication number Publication date
EP2138169B1 (fr) 2013-11-06
CN101843603A (zh) 2010-09-29
CN101843603B (zh) 2012-06-27
PL2138169T3 (pl) 2014-04-30
ATE457168T1 (de) 2010-02-15
RS51260B (sr) 2010-12-31
JO2606B1 (en) 2011-11-01
RS53182B (sr) 2014-06-30
UA89766C2 (en) 2010-03-10
EP1541137A3 (fr) 2005-11-16
DE602004025444D1 (de) 2010-03-25
HK1074801A1 (en) 2005-11-25
AR046762A1 (es) 2005-12-21
SV2006001970A (es) 2006-02-16
DK2138169T3 (da) 2013-11-18
CR8465A (es) 2007-06-06
PL1541137T3 (pl) 2010-07-30
SI1541137T1 (sl) 2010-06-30
SI2138169T1 (sl) 2014-03-31
EP1541137A2 (fr) 2005-06-15
PT2138169E (pt) 2014-02-17
TWI257299B (en) 2006-07-01
EP1541137B1 (fr) 2010-02-10
ES2340925T3 (es) 2010-06-11
HRP20140077T1 (hr) 2014-02-28
CY1110637T1 (el) 2015-04-29
HK1132682A1 (en) 2010-03-05
ME01069B (fr) 2012-10-20
DK1541137T3 (da) 2010-04-26
CY1115064T1 (el) 2016-12-14
MY144053A (en) 2011-08-15
EP2138169A2 (fr) 2009-12-30
TW200528073A (en) 2005-09-01
PT1541137E (pt) 2010-05-17
EP2138169A3 (fr) 2011-04-06
MY152750A (en) 2014-11-28
PE20051035A1 (es) 2006-02-08
HN2004000526A (es) 2010-02-01
GT200400262A (es) 2005-10-31
ES2445690T3 (es) 2014-03-04

Similar Documents

Publication Publication Date Title
HRP20100254T1 (hr) Transdermalni sustav za davanje gestodena
CN1136843C (zh) 含雌二醇的透皮治疗系统
RU2176499C2 (ru) Композиция для чрескожного введения стероидных лекарственных средств и содержащий ее препарат
AU652121B2 (en) Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
US5554381A (en) Low flux matrix system for delivering potent drugs transdermally
ES2655705T3 (es) Composición que comprende rotigotina, su uso y parche transdérmico que comprende la composición
CA2183543C (fr) Systemes therapeutiques transdermiques contenant des steroides sexuels
JP4346696B2 (ja) 経皮治療用装置
CA2785117C (fr) Systeme therapeutique transdermique servant a administrer de la rivastigmine ou ses derives
US20130053357A1 (en) Skin irritation suppressant and transdermal preparation
TW201201796A (en) Transdermal delivery patch
JPH04504109A (ja) エストロゲン／プロゲスチン経皮投与ユニット，そのシステムとプロセス
KR900005969A (ko) 게스토덴을 함유하는 경피 투여용 제제
US20100063014A1 (en) Drug comprising at least one gestagen
JPH06502429A (ja) 経皮避妊製剤、方法及びデバイス
KR880701114A (ko) 에스트라디올 및 기타 에스트로겐성 스테로이드용 경피 흡수 투여단위 및 그 투여방법
AR030037A1 (es) Sistema de administracion de anticonceptivo transdermico mejorado y el uso de una capa de soporte y una matriz polimerica para la fabricacion de un sistema de administracion de anticonceptivo
AU2018202501A1 (en) Once-a-day replacement transdermal administration of fentanyl
MXPA01000126A (es) Compuesto que contiene por lo menos un principio activo que incide en el indice de grasa en la sangre.
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia
RU2209090C2 (ru) Устройство для введения лекарственных препаратов через кожу, содержащее два активных начала в отдельных секциях, способ его изготовления и способ введения нескольких лекарственных препаратов
EP1057480B1 (fr) Thérapie transdermique à base d'un agoniste-antagoniste d' oestrogène
CA3239720A1 (fr) Systeme therapeutique transdermique pour l'administration transdermique de selexipag
KR100498199B1 (ko) 트리메게스톤경피투여용신규장치
KR20200025888A (ko) 장기 투여용 리바스티그민 패취